Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Nephrology
Volume 2017, Article ID 7143649, 5 pages
https://doi.org/10.1155/2017/7143649
Case Report

Discontinuation of Hemodialysis in a Patient with Anti-GBM Disease by the Treatment with Corticosteroids and Plasmapheresis despite Several Predictors for Dialysis-Dependence

1Department of Internal Medicine, Teikyo University School of Medicine, Itabashi-ku, Tokyo, Japan
2Central Laboratory, Teikyo University School of Medicine, Itabashi-ku, Tokyo, Japan

Correspondence should be addressed to Yoshihide Fujigaki; moc.liamg@edihihsoyikagijuf

Received 21 July 2017; Accepted 30 August 2017; Published 11 October 2017

Academic Editor: Kouichi Hirayama

Copyright © 2017 Yoshihide Fujigaki et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. P. McAdoo and C. D. Pusey, “Anti-Glomerular Basement Membrane Disease,” Clinical Journal of the American Society of Nephrology, vol. 12, no. 7, pp. 1162–1172, 2017. View at Publisher · View at Google Scholar
  2. J. P. Johnson, W. Whitman, W. A. Briggs, and C. B. Wilson, “Plasmapheresis and immunosuppressive agents in antibasement membrane antibody-induced Goodpasture's syndrome,” The American Journal of Medicine, vol. 64, no. 2, pp. 354–359, 1978. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Savage, C. D. Pusey, C. Bowman, A. J. Rees, and C. M. Lockwood, “Antiglomerular basement membrane antibody mediated disease in the British Isles 1980–4,” British Medical Journal (Clinical research ed.), vol. 292, no. 6516, pp. 301–304, 1986. View at Publisher · View at Google Scholar · View at Scopus
  4. C. R. K. Hind, C. M. Lockwood, D. K. Peters, H. Paraskevakou, D. J. Evans, and A. J. Rees, “Prognosis after immunosuppression of patients with crescentic nephritis requiring dialysis,” The Lancet, vol. 321, no. 8319, pp. 263–265, 1983. View at Publisher · View at Google Scholar · View at Scopus
  5. J. B. Levy, A. N. Turner, A. J. Rees, and C. D. Pusey, “Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression,” Annals of Internal Medicine, vol. 134, no. 11, pp. 1033–1042, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. B. Alchi, M. Griffiths, M. Sivalingam, D. Jayne, and K. Farrington, “Predictors of renal and patient outcomes in anti-GBM disease: clinicopathologic analysis of a two-centre cohort,” Nephrology Dialysis Transplantation, vol. 30, no. 5, pp. 814–821, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. I. Buhaescu, R. A. Yood, and H. Izzedine, “Serum procalcitonin in systemic autoimmune diseases—where are we now?” Seminars in Arthritis and Rheumatism, vol. 40, no. 2, pp. 176–183, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Morath, J. Sis, G. M. Haensch, M. Zeier, K. Andrassy, and V. Schwenger, “Procalcitonin as marker of infection in patients with Goodpasture's syndrome is misleading,” Nephrology Dialysis Transplantation, vol. 22, no. 9, pp. 2701–2704, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. Kidney Disease Improving Global Outcomes (KDIGO), “clinical practice guideline for glomerulonephritis,” Kidney International, Suppl 2, pp. 139–274, 2012. View at Google Scholar
  10. Q. Gu, L. Xie, X. Jia et al., “Fever and prodromal infections in anti-glomerular basement membrane disease,” Nephrology, 2017. View at Publisher · View at Google Scholar
  11. F. Merkel, O. Pullig, M. Marx, K. O. Netzer, and M. Weber, “Course and prognosis of anti-basement membrane antibody (anti-BM-Ab)-mediated disease: report of 35 cases,” Nephrology Dialysis Transplantation, vol. 9, no. 4, pp. 372–376, 1994. View at Google Scholar · View at Scopus
  12. M. Herody, G. Bobrie, C. Gouarin, J. P. Grunfeld, and L. H. Noel, “Anti-GBM disease: Predictive value of clinical, histological and serological data,” Clinical Nephrology, vol. 40, no. 5, pp. 249–255, 1993. View at Google Scholar · View at Scopus
  13. J. C. Flores, C. O. S. Savage, C. M. Lockwood et al., “Clinical and immunological evolution of oligoanuric anti-gbm nephritis treated by haemodialysis,” The Lancet, vol. 327, no. 8471, pp. 5–8, 1986. View at Publisher · View at Google Scholar · View at Scopus
  14. J. P. Johnson, J. Moore, H. A. Austin, J. E. Balow, T. T. Antonovych, and C. B. Wilson, “Therapy of anti-glomerular basement membrane antibody disease: Analysis of prognostic significance of clinical, pathologic and treatment factors,” Medicine, vol. 64, no. 4, pp. 219–227, 1985. View at Google Scholar · View at Scopus
  15. Z. Cui, J. Zhao, X.-Y. Jia et al., “Anti-glomerular basement membrane disease: Outcomes of different therapeutic regimens in a large single-center chinese cohort study,” Medicine, vol. 90, no. 5, pp. 303–311, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. C. M. Lockwood, A. J. Rees, T. A. Pearson, D. J. Evans, D. K. Peters, and C. B. Wilson, “Immunosuppression and plasma exchange in the treatment of Goodpasture's syndrome,” Lancet, vol. 1, no. 7962, pp. 711–715, 1976. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Tanabe, “Double-filtration plasmapheresis,” Transplantation, vol. 84, supp 12, no. 12, pp. S30–S32, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. N. Hajime, A. Michiko, K. Atsunori et al., “A case report of efficiency of double filtration plasmapheresis in treatment of goodpasture's syndrome,” Therapeutic Apheresis and Dialysis, vol. 13, no. 4, pp. 373–377, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. K. Laczika, S. Knapp, K. Derfler, A. Soleiman, W. H. Hörl, and W. Druml, “Immunoadsorption in Goodpasture's syndrome,” American Journal of Kidney Diseases, vol. 36, no. 2, pp. 392–395, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Biesenbach, R. Kain, K. Derfler et al., “Long-term outcome of anti-glomerular basement membrane antibody disease treated with immunoadsorption,” PLoS ONE, vol. 9, no. 7, article e103568, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. Y.-Y. Zhang, Z. Tang, D.-M. Chen, D.-H. Gong, D.-X. Ji, and Z.-H. Liu, “Comparison of double filtration plasmapheresis with immunoadsorption therapy in patients with anti-glomerular basement membrane nephritis,” BMC Nephrology, vol. 15, no. 1, article no. 128, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. Z. Qu, Z. Cui, G. Liu, and M.-H. Zhao, “The distribution of IgG subclass deposition on renal tissues from patients with anti-glomerular basement membrane disease,” BMC Immunology, vol. 14, no. 1, article no. 19, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Haubitz, F. Bohnenstengel, R. Brunkhorst, M. Schwab, U. Hofmann, and D. Busse, “Cyclophosphamide pharmacokinetics and dose requirements in patients with renal insufficiency,” Kidney International, vol. 61, no. 4, pp. 1495–1501, 2002. View at Publisher · View at Google Scholar · View at Scopus